Evidence map›Paper›PMID 23676894›Full record

ArticleJournal of the Royal Society, Interface2013

Directed evolution of bacteriorhodopsin for applications in bioelectronics.

Nicole L Wagner, Jordan A Greco, Matthew J Ranaghan, Robert R Birge

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Journal of chemical theory and computation · 2025
    Article
  3. Article
  4. Article
  5. Light Color-Controlled pH-Adjustment of Aqueous Solutions Using Engineered Proteoliposomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicole L WagnerDepartment of Molecular & Cell Biology, University of Connecticut, Storrs, CT 06269-3125, USA.
Jordan A Greco
Matthew J Ranaghan
Robert R Birge

Funding

PHOTOPHYSICS OF VISUAL CHROMOPHORES AND RHODOPSINR01GM034548 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI BIRGE, ROBERT RICHARDS · 1985 to 2012
$1.9M
NIGMS NIH HHS GM-34548NIGMS NIH HHS R01 GM034548
6 · The paper itself

Abstract

In nature, biological systems gradually evolve through complex, algorithmic processes involving mutation and differential selection. Evolution has optimized biological macromolecules for a variety of functions to provide a comparative advantage. However, nature does not optimize molecules for use in human-made devices, as it would gain no survival advantage in such cooperation. Recent advancements in genetic engineering, most notably directed evolution, have allowed for the stepwise manipulation of the properties of living organisms, promoting the expansion of protein-based devices in nanotechnology. In this review, we highlight the use of directed evolution to optimize photoactive proteins, with an emphasis on bacteriorhodopsin (BR), for device applications. BR, a highly stable light-activated proton pump, has shown great promise in three-dimensional optical memories, real-time holographic processors and artificial retinas.

Indexed as

Directed Molecular EvolutionBacteriorhodopsinsBioengineeringComputer Storage DevicesElectronics, MedicalHolographyHumansModels, BiologicalMolecular StructureMutagenesisNanotechnologyVisual ProsthesisBacteriorhodopsinsbacteriorhodopsinbionanotechnologydirected evolutionphotoactive proteinsprotein-based devicesretinal proteins

Identifiers

PMID23676894
PMCPMC3673155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.